5840 |
A Case of Evolut Valve Migration for TAV in SAV |
Kentaro Hayashida |
Aug. 04. 23 |
5839 |
Repeated Recurrent Restenosis in a Patient with Delayed Coronary Obstruction after TAVR |
Wei-Hsian Yin |
Aug. 04. 23 |
5838 |
Case of Transcatheter Heart Valve Embolrization in the Patient with Kyphosis |
Ju Han Kim |
Aug. 04. 23 |
5837 |
Unexpected Transcatheter Valve Frame Collapse, All Hands On Deck |
Nicolas Van Mieghem |
Aug. 04. 23 |
5836 |
HALT-Pathologic Underpinnings |
Aloke V. Finn |
May. 08. 23 |
5835 |
Should Jardiance be Used as 1st Essential Medication for Heart Failure, Regardless of LVEF? |
Kyung Hoon Cho |
Apr. 20. 23 |
5834 |
Jardiance, The First Successful Result for Heart Failure with Preserved Ejection Fraction |
Wonjae Lee |
Apr. 20. 23 |
5833 |
My First Impression on using Sentinel Device during TAVI |
Si-Hyuck Kang |
Apr. 20. 23 |
5832 |
Why Should We Consider ACURATE neo2 ? - Based on Clinical Evidence |
Jeehoon Kang |
Apr. 20. 23 |
5831 |
Introduction to a New TAVI Valve - ACURATE neo2 |
Cheol Woong Yu |
Apr. 20. 23 |